EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Advances in the Use of Lipids for Drug Delivery Systems

Dr. John Smith

American Journal of Pharmaceutics · 2022-02-28 · 3 (1) · 32-42

DOI: 10.71465/ajph2164 ↗

At a glance

Journal article in American Journal of Pharmaceutics, published online on 2022-02-28. Written by Dr. John Smith. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Lipids have gained significant attention in drug delivery systems due to their biocompatibility, ease of functionalization, and ability to encapsulate a wide range of therapeutic agents. Lipid-based carriers such as liposomes, lipid nanoparticles (LNPs), and solid lipid nanoparticles (SLNs) have revolutionized the pharmaceutical industry by offering controlled release, targeted delivery, and enhanced bioavailability. This article explores the advancements in lipid-based drug delivery systems, their mechanisms, applications, and challenges in clinical settings. Current innovations in lipid formulations and their role in personalized medicine are also discussed. These systems hold potential for improving the treatment of various diseases, particularly cancer, viral infections, and neurological disorders.

Cite

APA

Smith, D. J. (2022). Advances in the Use of Lipids for Drug Delivery Systems. American Journal of Pharmaceutics, 3(1), 32-42. https://doi.org/10.71465/ajph2164

Vancouver

Smith DJ. Advances in the Use of Lipids for Drug Delivery Systems. American Journal of Pharmaceutics. 2022;3(1):32-42. doi:10.71465/ajph2164

BibTeX
@article{Smith2022,
  author = {Smith, Dr. John},
  title = {Advances in the Use of Lipids for Drug Delivery Systems},
  journal = {American Journal of Pharmaceutics},
  year = {2022},
  volume = {3},
  number = {1},
  pages = {32--42},
  doi = {10.71465/ajph2164}
}
Start for free →